IP Verse

Genentech vs. Celltrion Healthcare Belgium - UPC_CFI_165/2024

The case UPC_CFI_165/2024 was filed by the plaintiff Genentech, Novartis against the defendant Celltrion Healthcare Belgium on 09 Apr, 2024.

Case Timeline

09 Apr, 2024
Case Filed
27 Jun, 2024
Rejoinder
27 Jun, 2024
Oral Procedure
Today Nov 1, 2025
Decision

Case Details

    Case Number:

    UPC_CFI_165/2024

    Patent Number:

    EP3805248

    Filing Date:

    09 Apr, 2024

    Proceeding Type:

    Provisionalmeasures

    Case Phase:

    Case Closed

    Plaintiffs:

    • Genentech
    • Novartis

    Plaintiff Representative:

    • Kilian Seidel

    Defendants:

    • Celltrion Healthcare Belgium
    • Celltrion Healthcare Deutschland
    • Celltrion Healthcare Finland
    • Celltrion Healthcare France
    • Celltrion Healthcare Hungary KFT
    • Celltrion Healthcare Italy
    • Celltrion Healthcare Netherlands

    Defendant Representative:

    • Emilia Zalewska

    Judges:

    • Alima Zana
    • Berenice Thom
    • John Petersen
    • Ronny Thomas

    Court Division:

    First Instance, Local Division - Dusseldorf

Case Decision

Decision pending - set alert to receive updates

Docket Entries

The docket entries provide a comprehensive overview of all filings, motions, orders, and other significant actions taken in the case.

Last updated on: Oct 30, 2025
DateTitle

Notify me when new UPC document is filed

Mar 27, 2025Case Closure Formal Check
Sep 6, 2024Measures Decisionoutcome Notification
Sep 6, 2024Headnote And Keywords
Sep 6, 2024Final Order On Pi Application
Sep 6, 202418492 2024 Oh Dus Loc Upc202407310930Am S04
Sep 6, 202418492 2024 Oh Dus Loc Upc202407310930Am S03
Sep 6, 202418492 2024 Oh Dus Loc Upc202407310930Am S02
Sep 6, 202418492 2024 Oh Dus Loc Upc202407310930Am S01
Sep 3, 2024Submission Of Epo Preliminary Opinion
Sep 3, 2024Receipt
Sep 3, 2024Exhibit Fbd 46
Jul 24, 2024Time Limits For Parties' Oral Submissions
Jun 27, 2024Rejoinder Upc Celltrion V Novartis (Signed)
Jun 27, 2024Bb49 Expert Declaration Dr. L. De Leede Of 26 June
Jun 27, 2024Bb49B Annexes To Expert Declaration Dr. L. De Leede Of 26 June
Jun 27, 2024Bb49A Cv Of Dr. L. De Leede
Jun 27, 2024Bb48 Notice From The Epo Regarding Accelerated Proceedings Of 17 June
Jun 27, 2024Bb47 Presta Et Al J Immunol 1993 VOL 151 No 5 P 2623 2632
Jun 27, 2024Bb46 Cacia Et Al Biochemistry 1996 VOL 35 No 6 P 1897 1903
Jun 27, 2024Bb45 Expert Declaration Prof. Dr. T. Dingermann Of 26 June
Jun 27, 2024Bb45B Annexes To Expert Declaration Of Prof. Dr. T. Dingermann
Jun 27, 2024Bb45A Cv Of Prof. Dr. T. Dingermann
Jun 27, 2024Bb44 Expert Declaration Prof. Dr. H.W. Frijlink Of 26 June (Expert Declaration Of Prof. Dr. H.W. Frijlink Ii)
Jun 27, 2024Bb44A Annexes To Expert Declaration Of Prof. Dr. H.W. Frijlink Ii
Jun 27, 2024Bb43 Witness Statement Of Dongkyu Kim
Jun 27, 2024Bb43A Exhibit 1 To Witness Statement Of Dongkyu Kim
Jun 27, 2024Bb42 Witness Statement Annelies VAN Leeuwen
Jun 27, 2024Bb41 Witness Statement Bart Buiks
Jun 27, 2024Bb40 Witness Statement Joel VAN Ruyskensvelde
Jun 27, 2024Bb39 Witness Statement Taeksang Kwon
Jun 27, 2024Bb38 Higher Regional Court Dusseldorf Judgment Of (I 2 U 44 12)
Jun 27, 2024Bb38A English Machine Translation Of Exhibit Bb38
Jun 27, 2024Acknowledgement Of Lodging
Jun 14, 2024Template Order
Jun 14, 2024Procedural Order
Jun 14, 2024Outcome Of The Order
Jun 7, 2024Receipt
Jun 7, 2024Exhibit Fbd 45A
Jun 7, 2024Exhibit Fbd 45
Jun 7, 2024Exhibit Fbd 44
Jun 7, 2024Exhibit Fbd 43
Jun 7, 2024Exhibit Fbd 42
Jun 7, 2024Exhibit Fbd 41
Jun 7, 2024Exhibit Fbd 40 (Conf)
Jun 7, 2024Exhibit Fbd 39 (Conf)
Jun 7, 2024Exhibit Fbd 38 (Conf)
Jun 7, 2024Exhibit Fbd 37 (Conf)
Jun 7, 2024Exhibit Fbd 36 (Conf)
Jun 7, 2024Exhibit Fbd 36A (Conf)
Jun 7, 2024Exhibit Fbd 35
Jun 7, 2024Exhibit Fbd 34
Jun 7, 2024Application Pursuant To R. 9 Rop Upc
Jun 7, 202424 06 06 Xolair EP248 VS Celltrion Eu Reply
Jun 7, 202424 06 06 Application Pursuant To R. 262.2 Rop Upc
May 16, 2024Summons
May 16, 2024Procedural Order Oral Hearing
May 16, 2024Panel Appointment
May 16, 2024Document Technical Reason
May 14, 2024Objection Upc Celltrion V Novartis (Signed)
May 14, 2024Bb37 EP1786830B1
May 14, 2024Bb36 Hernandez Et Al.
May 14, 2024Bb35 Jp H04 198195
May 14, 2024Bb35A Jp H04 198195 Translation Of Description
May 14, 2024Bb34 WO9006764A1
May 14, 2024Bb33 Wo A2
May 14, 2024Bb32 EP0025275A2
May 14, 2024Bb31 Chen Et Al. Pharmaceutical Research VOL. 20 No. 12 P. 1952 60 (Chen)
May 14, 2024Bb30 CR Ommelin Pharmaceutical Biotechnology Fundamentals And Applications (Second Edition)
May 14, 2024Bb29 EP1610820B2
May 14, 2024Bb28 Letter Novartis Regarding Submission Of Patentees 18 July
May 14, 2024Bb27 Statement Of Defence By Novartis In The Dutch Proceedings 3 April
May 14, 2024Bb27A English Machine Translation Of Statement Of Defence By Novartis 3 April
May 14, 2024Bb26O Third Party Observation 24 May
May 14, 2024Bb26N Notice Examiner 31 January
May 14, 2024Bb26M Letter Novartis Regarding Third Party Observation 4 October
May 14, 2024Bb26L Third Party Observation 22 September
May 14, 2024Bb26K Yadav Et Al. Pharmaceutical Research VOL. 28 P. Submitted By Letter Of Novartis 26 July (Yad
May 14, 2024Bb26J Liu Et Al. Journal Of Pharmaceutical Sciences VOL. 94 P. Submitted By Letter Of Novartis 26 July
May 14, 2024Bb26I Tomar Et Al. Journal Of The Taylor Francis Group VOL. 9 P. 476 489 Submitted By Letter Of Novartis 26 July
May 14, 2024Bb26H Adjusted Claims 1 3 By Letter Of Novartis 26 July
May 14, 2024Bb26G Letter Novartis Regarding The Adjustment Of The Claims 26 July
May 14, 2024Bb26F European Search Report 31 May
May 14, 2024Bb26E European Search Opinion 10 June
May 14, 2024Bb26D Letter Novartis On Submission Of Claims 1 21 3 November
May 14, 2024Bb26C Claims 1 21 Submitted By Letter Of Novartis 3 November
May 14, 2024Bb26B Letter Epo To Remedy Deficiencies (Submission Of Claims) 28 October
May 14, 2024Bb26A International Search Report 12 April
May 14, 2024Bb25 Decision Of The Board Of Appeal Epo On EP6365May
May 14, 2024Bb24 EP4108259A1
May 14, 2024Bb23 EP4104859A1
May 14, 2024Bb22 Technical Primer For The Patent
May 14, 2024Bb21 Expert Declaration Of Prof. Dr. H.W. Frijlink On Arginine(Hcl) (Expert Declaration Of Prof. Frijlink I)
May 14, 2024Bb21B Annexes To The Expert Declaration Of Prof. Dr. H.W. Frijlink
May 14, 2024Bb21A Cv Of Prof. Dr. H.W. Frijlink
May 14, 2024Bb20 EP2116265B1
May 13, 2024Order Tqj
May 13, 2024Consent To Allocation Of Technically Qualified Judge
May 10, 2024Consent To The Appointment Of A Tqj
May 2, 2024Repeated Upload Of Order DATED 10 April
May 2, 2024Pre Order Tqj
Apr 23, 2024Date Of A Possible Oral Hearing
Apr 18, 2024Service To Defendants 1 To 7
Apr 18, 2024Service To Defendant 1 To 7
Apr 18, 2024Confirmation Of Notification Of Appointment
Apr 18, 2024Acknowledgement Of Access To Case
Apr 12, 2024Letter For Service
Apr 11, 2024Panel Appointment
Apr 10, 2024R.207.8 Order
Apr 9, 2024Receipt
Apr 9, 2024Panel Appointment
Apr 9, 2024Formal Checks Notification Of Positive Outcome
Apr 9, 2024Exhibit Fbd 9
Apr 9, 2024Exhibit Fbd 8
Apr 9, 2024Exhibit Fbd 7
Apr 9, 2024Exhibit Fbd 6
Apr 9, 2024Exhibit Fbd 5 (Confidential)
Apr 9, 2024Exhibit Fbd 4
Apr 9, 2024Exhibit Fbd 33
Apr 9, 2024Exhibit Fbd 32
Apr 9, 2024Exhibit Fbd 31
Apr 9, 2024Exhibit Fbd 30
Apr 9, 2024Exhibit Fbd 3
Apr 9, 2024Exhibit Fbd 29
Apr 9, 2024Exhibit Fbd 28
Apr 9, 2024Exhibit Fbd 27
Apr 9, 2024Exhibit Fbd 26
Apr 9, 2024Exhibit Fbd 25
Apr 9, 2024Exhibit Fbd 24
Apr 9, 2024Exhibit Fbd 23
Apr 9, 2024Exhibit Fbd 22
Apr 9, 2024Exhibit Fbd 21 1
Apr 9, 2024Exhibit Fbd 21
Apr 9, 2024Exhibit Fbd 20
Apr 9, 2024Exhibit Fbd 2
Apr 9, 2024Exhibit Fbd 19
Apr 9, 2024Exhibit Fbd 18
Apr 9, 2024Exhibit Fbd 17
Apr 9, 2024Exhibit Fbd 16
Apr 9, 2024Exhibit Fbd 15
Apr 9, 2024Exhibit Fbd 14
Apr 9, 2024Exhibit Fbd 13
Apr 9, 2024Exhibit Fbd 12A
Apr 9, 2024Exhibit Fbd 12
Apr 9, 2024Exhibit Fbd 11
Apr 9, 2024Exhibit Fbd 10
Apr 9, 2024Exhibit Fbd 1
Apr 9, 2024Application To Request Confidentiality From The Public (Rop262.2)
Apr 9, 2024Application For Provisional Measures
Apr 9, 2024Application For Measures Receipt
Apr 9, 2024Application For Measures Acknowledgement

More cases involving EP3805248B1

This table lists the related cases associated with the patent, including case numbers, plaintiffs, and defendants involved in each case.

Last updated on: Oct 30, 2025
Case NumberFiling DatePlaintiffsDefendants
APP_61187/2024Nov 14, 2024Cohausz & FlorackCelltrion, Genentech, Novartis
APP_61203/2024Nov 14, 2024Cohausz & FlorackCelltrion Healthcare Belgium, Celltrion Healthcare Deutschland, Celltrion Healthcare Finland, Celltrion Healthcare France, Celltrion Healthcare Hungary KFT, Celltrion Healthcare Italy, Celltrion Healthcare Netherlands, Genentech, Novartis
ACT_18492/2024Apr 9, 2024Genentech, NovartisCelltrion Healthcare Belgium, Celltrion Healthcare Deutschland, Celltrion Healthcare Finland, Celltrion Healthcare France, Celltrion Healthcare Hungary KFT, Celltrion Healthcare Italy, Celltrion Healthcare Netherlands

More cases involving Genentech

This table lists the related cases associated with the patent, including case numbers, plaintiffs, and defendants involved in each case.

Last updated on: Oct 30, 2025
Case NumberFiling DatePlaintiffsDefendants
ACT_21478/2025May 6, 2025GenentechOrganon, Organon Heist, Shanghai Henlius Biotech
ACT_21486/2025May 6, 2025GenentechOrganon, Organon Heist, Shanghai Henlius Biotech
UPC_CFI_407/2025May 6, 2025GenentechOrganon, Organon Heist, Shanghai Henlius Biotech

More cases involving Celltrion Healthcare Belgium

This table lists the related cases associated with the patent, including case numbers, plaintiffs, and defendants involved in each case.

Last updated on: Oct 30, 2025
Case NumberFiling DatePlaintiffsDefendants
APP_61203/2024Nov 14, 2024Cohausz & FlorackCelltrion Healthcare Belgium
ORD_43328/2024Jul 24, 2024Genentech, NovartisCelltrion Healthcare Belgium
ORD_25043/2024May 2, 2024Genentech, NovartisCelltrion Healthcare Belgium